Rabbit Anti-KCNQ4 Recombinant Antibody (EG1771) (CBMAB-EN2110-LY)

Zhang, Y., Dong, X., Guo, X., Li, C., Fan, Y., Liu, P., ... & Gao, P. (2023). LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer. Molecular cancer, 22(1), 1-19.

Oh, K. S., Roh, J. W., Joo, S. Y., Ryu, K., Kim, J. A., Kim, S. J., ... & Gee, H. Y. (2023). Overlooked KCNQ4 variants augment the risk of hearing loss. Experimental & Molecular Medicine, 55(4), 844-859.

Homma, K. (2022). The Pathological Mechanisms of Hearing Loss Caused by KCNQ1 and KCNQ4 Variants. Biomedicines, 10(9), 2254.

Zheng, H., Yan, X., Li, G., Lin, H., Deng, S., Zhuang, W., ... & Yan, Z. (2022). Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4. Genome Research, 32(8), 1573-1584.

Thorpe, R. K., Walls, W. D., Corrigan, R., Schaefer, A., Wang, K., Huygen, P., ... & Smith, R. J. (2022). AudioGene: refining the natural history of KCNQ4, GSDME, WFS1, and COCH-associated hearing loss. Human genetics, 141(3-4), 877-887.

Rim, J. H., Choi, J. Y., Jung, J., & Gee, H. Y. (2021). Activation of KCNQ4 as a therapeutic strategy to treat hearing loss. International journal of molecular sciences, 22(5), 2510.

Li, T., Wu, K., Yue, Z., Wang, Y., Zhang, F., & Shen, H. (2021). Structural basis for the modulation of human KCNQ4 by small-molecule drugs. Molecular Cell, 81(1), 25-37.

Lee, S. Y., Choi, H. B., Park, M., Choi, I. S., An, J., Kim, A., ... & Choi, B. Y. (2021). Novel KCNQ4 variants in different functional domains confer genotype-and mechanism-based therapeutics in patients with nonsyndromic hearing loss. Experimental & Molecular Medicine, 53(7), 1192-1204.

Jung, J., Lin, H., Koh, Y. I., Ryu, K., Lee, J. S., Rim, J. H., ... & Gee, H. Y. (2019). Rare KCNQ4 variants found in public databases underlie impaired channel activity that may contribute to hearing impairment. Experimental & molecular medicine, 51(8), 1-12.

Shin, D. H., Jung, J., Koh, Y. I., Rim, J. H., Lee, J. S., Choi, H. J., ... & Gee, H. Y. (2019). A recurrent mutation in KCNQ4 in Korean families with nonsyndromic hearing loss and rescue of the channel activity by KCNQ activators. Human mutation, 40(3), 335-346.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols